In this webinar, IQVIA experts will focus on the medical technology (MedTech) environment, examining how and why RWE is imperative and should be leveraged early in planning stages. The speakers will explore ways in which RWE studies can provide meaningful support for research, marketing, clinical, regulatory decision making, and reimbursement requirements.

The presentation will be of most interest for those in the medical device, diagnostic, and equipment space, with roles related to medical affairs, HEOR, regulatory, reimbursement, or RWE.

Share this invitation with a colleague, and we look forwarding to seeing you there!

Key Learning Objectives:

Understand how RWE strategies can be used to support development needs in the medical technology arena, including research initiatives, market development, and reimbursement planning, using comparative effectiveness analyses.

  • Review how rich data sources used in real world evidence studies (e.g., claims data, laboratory data, EMRs, etc.) can be used to support clinical evidence requirements.
  • Explore how RWE studies can support regulatory affairs strategies to satisfy market approval requirements.
  • Learn how linked/integrated data sources provide options to support evidence development requirements.
  • Understand what is needed for success as it relates to the evolving MedTech regulatory landscape and how RWE is being used for regulatory decision-making.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.